PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $2,404,000 | +311.6% | 27,500 | +75.3% | 0.03% | +312.5% |
Q1 2017 | $584,000 | +21.2% | 15,690 | 0.0% | 0.01% | +33.3% |
Q4 2016 | $482,000 | -91.5% | 15,690 | -81.4% | 0.01% | -90.2% |
Q3 2016 | $5,666,000 | +30.5% | 84,500 | -42.0% | 0.06% | +38.6% |
Q2 2016 | $4,343,000 | +110.3% | 145,800 | +107.4% | 0.04% | +193.3% |
Q1 2016 | $2,065,000 | -42.7% | 70,300 | +52.8% | 0.02% | -31.8% |
Q4 2015 | $3,606,000 | – | 46,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |